News in the antifungal world: new drugs and resistance mechanisms
Friday, July 9, 2021
6. Fungal infection & disease, 1-hour Oral Session
•
S103
•
1:15 PM
>
2:15 PM
•
News in the antifungal world: new drugs and resistance mechanisms
•
6. Fungal infections
1:15 PM
•
2993
•
EUCAST ibrexafungerp (SCY-078) MICs for contemporary Danish yeast isolates
>
M.
Maiken Cavling
ARENDRUP (Copenhagen)
1:25 PM
•
1046
•
Activity of manogepix, the active moiety of fosmanogepix against infrequently encountered yeast and mould isolates from the SENTRY antimicrobial surveillance programme (2017-2019)
>
M.
Michael D.
HUBAND (North Liberty)
1:35 PM
•
2708
•
In-host acquisition of high-level amphotericin B resistance and identification of the first mechanism of clinical amphotericin B resistance in <em>Candida auris</em>
>
J.
Jeffrey
RYBAK (Memphis)
1:45 PM
•
1362
•
<em>Candida parapsilosis</em> clinical azole cross-resistance acquisition is prompted by <em>MRR1</em> gain-of-function mutation
>
J.
Joana
BRANCO (Porto)
1:55 PM
•
3138
•
Analysis of multiple resistance genes in <em>Candida glabrata</em> using targeted resequencing with multiplex long-range PCR
>
K.
Kathrin
SPETTEL (Vienna)
2:05 PM
•
INT9
•
Q&A/Discussion
|